Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
—1,062.401,064.141,071.991,061.02——
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
—606.74606.74609.84602.33——
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
—1,238.211,236.601,247.741,232.10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
—1,718.611,723.231,741.481,717.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
—637.37638.27642.30638.27——
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
—853.59854.05858.19851.34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
—218.33218.33219.73217.15——
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
—3,594.813,620.103,657.473,615.34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
—908.54909.50917.35907.07——
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
—1,495.001,499.611,517.101,499.61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
—2,398.312,406.822,421.802,404.22——
4553:TYO
Towa Pharmaceutical Co Ltd
¥3,885.00
-1.27%
(-50.00) 1D
May 26, 9:44:11 AM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4553...
Open
¥3,885
High
¥3,905
Low
¥3,850
Mkt. cap
199.37B
Avg. vol.
149.01K
Volume
23.20K
Dividend
2.06%
Quarterly dividend
¥20
Ex-dividend date
Mar 30, 2026
P/E ratio
36.43
52-wk high
¥4,490
52-wk low
¥2,764
EPS
¥107
Shares outstanding
16.40M
No. of employees
5K
News stories
From sources across the web
About Towa Pharmaceutical Co Ltd
CEO-
Employees4.79K
Founded1951
Headquarters-
SectorPharmaceutical industry
Websitetowayakuhin.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
65.15B
65.33B
73.59B
69.64B
Cost of goods sold
41.47B
41.80B
45.67B
45.66B
Cost of revenue
41.47B
41.80B
45.67B
45.66B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.47B
18.29B
18.87B
20.37B
Operating expense
18.47B
18.29B
18.87B
20.37B
Total operating expenses
59.94B
60.09B
64.54B
66.03B
Operating income
5.21B
5.24B
9.05B
3.61B
Other non operating income
-1.16B
1.50B
3.31B
-4.49B
EBT including unusual items
3.96B
8.00B
12.00B
-10.79B
EBT excluding unusual items
3.95B
6.47B
12.01B
-1.29B
Income tax expense
1.45B
2.29B
3.13B
1.05B
Effective tax rate
36.54%
28.69%
26.07%
-9.70%
Other operating expenses
-
-
-
-
Net income
2.51B
5.70B
8.87B
-11.83B
Net profit margin
3.86%
8.73%
12.05%
-16.99%
Earnings per share
-
-
-
-
Interest and investment income
67.00M
93.00M
76.00M
89.00M
Interest expense
-540.00M
-609.00M
-532.00M
-580.00M
Net interest expenses
-473.00M
-516.00M
-456.00M
-491.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
10.46B
10.89B
14.93B
9.66B
Gain or loss from assets sale
-8.00M
32.00M
14.00M
14.80B
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer